86exporter.com Home       Products Catalog      Suppliers Catalog      Log In        Sign up
      About Us
      Profile
      Products
      Contact Us

 


Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd

Products >> Tilmicosin 30% Injectable Solution

Tilmicosin 30% Injectable Solution

Build Your Online Product Catalogs?



Description
Product Name: Tilmicosin 30% Injectable Solution
Supply Ability:
Related proudcts
Specifications 100ml
Price Term:
Port of loading:
Minimum Order
Unit Price:

Composition:
Contains per ml:
Tilmicosin (as phosphate) ¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­ 300 mg.
Solvents ad ¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­¡­ 1 ml.

Description:
Tilmicosin is a broad-spectrum semi-synthetic bactericidal macrolide antibiotic synthesized from tylosin. It has an antibacterial spectrum that is predominantly effective against Mycoplasma, Pasteurella and Haemophilus spp. and various Gram-positive organisms such as Staphylococcus spp. It is believed to affect bacterial protein synthesis. Cross-resistance between tilmicosin and other macrolide antibiotics has been observed. Following subcutaneous injection, tilmicosin is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine.

Indications:
Tilmicosin 30% injection is indicated for the treatment of respiratory infections in cattle and sheep associated with Mannheimia haemolytica, Pasteurella spp. and other tilmicosin-susceptible micro-organisms, and for the treatment of ovine mastitis associated with Staphylococcus aureus and Mycoplasma spp. Additional indications include the treatment of interdigital necrobacillosis in cattle (bovine pododermatitis, foul in the foot) and ovine footrot.

Contra-indications:
Hypersensitivity or resistance to tilmicosin.
Concurrent administration of other macrolides, lincosamides or ionophores.
Administration to equine, porcine or caprine species.
Administration to cattle producing milk for human consumption or to lambs weighing 15 kg or less.
Intravenous administration.
Do not use in lactating animals. During pregnancy, use only after a risk/benefit assessment by a veterinarian. Do not use in heifers within 60 days of calving.
Do not use together with adrenalin or ¦Â-adrenergic antagonists such as propranolol.

Side effects:
Occasionally, a soft diffuse swelling may occur at the injection site which subsides without further treatment. The acute manifestations of multiple injections of large subcutaneous doses (150 mg/kg) in cattle included moderate electrocar

Contact Us
Company: Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd
Contact: Mr. Jimmy Liu
Address: No. 16 Zhenzhu Road, Xinzhaidian Industry Park, Zhaoxian County, Shijiazhuang City
Postcode:
Tel: +86 13673212612
Fax: 86 311 84752785
E-mail:         


Copyright© Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd All Rights Reserved.
Tel : +86 13673212612 Fax : 86 311 84752785
Powered by 86exporter.com